Idiopathic Hypersomnia clinical trials at UCSF

1 research study open to eligible people

Showing trials for

  • ALKS 2680 in Subjects With Idiopathic Hypersomnia

    open to eligible people ages 18-70

    The purpose of this study is to measure the safety and decrease in daytime sleepiness in subjects with Idiopathic Hypersomnia when taking ALKS 2680 tablets compared with placebo tablets

    San Francisco 5391959, California 5332921 and other locations

Last updated: